• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-(4,6-二甲基-2-吡啶基)苯甲酰胺的合成及其对中枢多巴胺能的影响

Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.

作者信息

Bouhayat S, Piessard S, Le Baut G, Sparfel L, Petit J Y, Piriou F, Welin L

出版信息

J Med Chem. 1985 May;28(5):555-9. doi: 10.1021/jm50001a004.

DOI:10.1021/jm50001a004
PMID:4039368
Abstract

N-(4,6-Dimethyl-2-pyridinyl)benzamides 1-24 and the corresponding tertiary derivatives 29-33 were synthesized and studied for possible dopamine-inhibitory properties by testing their effect on motility of naive and reserpinized mice. Unlike the orthopramides, they failed to show any antidopaminergic properties, but some of the secondary derivatives showed instead effects of postsynaptic dopaminergic agonism. The latter compounds were subsequently studied for their effects on apomorphine reversal of reserpine-induced akinesia and on cerebral HVA levels in rats. Contraversive circling induced by compound 11 in 6-hydroxydopamine-lesioned mice suggests that a direct mechanism was involved.

摘要

合成了N-(4,6-二甲基-2-吡啶基)苯甲酰胺1-24以及相应的叔衍生物29-33,并通过测试它们对未用药和利血平化小鼠运动能力的影响,研究其可能的多巴胺抑制特性。与邻苯甲酰胺不同,它们未表现出任何抗多巴胺能特性,但一些仲衍生物反而表现出突触后多巴胺能激动作用。随后研究了后一类化合物对利血平诱导的运动不能的阿扑吗啡逆转作用以及对大鼠脑内高香草酸水平的影响。化合物11在6-羟基多巴胺损伤小鼠中诱导的反向旋转表明涉及直接机制。

相似文献

1
Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.N-(4,6-二甲基-2-吡啶基)苯甲酰胺的合成及其对中枢多巴胺能的影响
J Med Chem. 1985 May;28(5):555-9. doi: 10.1021/jm50001a004.
2
Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.多巴胺耗竭剂急性治疗增强阿扑吗啡诱导的刻板行为:D1多巴胺受体刺激增加的潜在作用。
Neuropharmacology. 1989 Sep;28(9):931-9. doi: 10.1016/0028-3908(89)90192-5.
3
Benzamide potentiation of behavioral apomorphine-induced effects; mechanism involved.苯甲酰胺对行为性阿扑吗啡诱导效应的增强作用;涉及的机制。
Experientia. 1985 Nov 15;41(11):1409-10. doi: 10.1007/BF01950008.
4
The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.改变纹状体多巴胺水平的药物对阿扑吗啡诱导的刻板行为的影响。
Pharmacol Biochem Behav. 1982 Feb;16(2):235-40. doi: 10.1016/0091-3057(82)90154-x.
5
Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).关于D145(1,3-二甲基-5-氨基金刚烷)的神经药理学研究。
Psychopharmacologia. 1975 Jul 23;43(1):53-61. doi: 10.1007/BF00437615.
6
Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.儿茶酚胺受体激动剂:对小鼠脑运动活性及酪氨酸羟化速率的影响
Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):167-76. doi: 10.1007/BF00498588.
7
REM sleep deprivation decreases apomorphine-induced stimulation of locomotor activity but not stereotyped behavior in mice.快速眼动睡眠剥夺可降低阿扑吗啡诱导的小鼠运动活性刺激,但不影响刻板行为。
Gen Pharmacol. 1992 May;23(3):337-41. doi: 10.1016/0306-3623(92)90092-x.
8
Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.HW-165及其对映体的中枢多巴胺能特性;3-PPP的反式八氢苯并(f)喹啉同系物
Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):205-18. doi: 10.1007/BF00512931.
9
7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.7-[3-(4-[2,3-二甲基苯基]哌嗪基)丙氧基]-2(1H)-喹啉酮(OPC-4392),一种突触前多巴胺自身受体激动剂和突触后D2受体拮抗剂。
Life Sci. 1988;42(20):1941-54. doi: 10.1016/0024-3205(88)90493-6.
10
Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
J Pharm Pharmacol. 1980 Jan;32(1):39-44. doi: 10.1111/j.2042-7158.1980.tb12842.x.

引用本文的文献

1
Newly discovered anti-inflammatory properties of the benzamides and nicotinamides.苯甲酰胺和烟酰胺新发现的抗炎特性。
Mol Cell Biochem. 1999 Mar;193(1-2):119-25.